论文部分内容阅读
目的:探讨利奈唑胺与万古霉素治疗耐甲氧西林金葡菌所致呼吸机相关性肺炎的比较情况。方法:分析我院收治的耐甲氧西林金葡菌所致呼吸机相关性肺炎患者临床资料,依据治疗方式不同分为利奈唑胺治疗组30例与万古霉素治疗组30例。结果:利奈唑胺治疗组耐甲氧西林金葡菌所致呼吸机相关性肺炎患者临床治疗总有效率明显高于万古霉素治疗组,P<0.05,差异有统计学意义。结论:利奈唑胺治疗组耐甲氧西林金葡菌所致呼吸机相关性肺炎患者临床治疗效果明显,预后良好,值得临床推广应用。
Objective: To investigate the comparison between linezolid and vancomycin in treating ventilator-associated pneumonia caused by methicillin-resistant Staphylococcus aureus. Methods: The clinical data of patients with ventilator-associated pneumonia caused by methicillin-resistant Staphylococcus aureus in our hospital were analyzed. According to the different treatment methods, 30 cases were treated with linezolid and 30 cases were treated with vancomycin. Results: The total effective rate of clinical treatment of patients with ventilator-associated pneumonia caused by methicillin-resistant Staphylococcus aureus in linezolid treatment group was significantly higher than that of vancomycin treatment group, P <0.05, the difference was statistically significant. Conclusion: Linezolid treatment group is resistant to methicillin-resistant Staphylococcus aureus-induced ventilator-associated pneumonia in patients with clinical treatment effect is obvious, the prognosis is good, worthy of clinical application.